XML 34 R23.htm IDEA: XBRL DOCUMENT

Subsequent Events	3 Months Ended
Subsequent Events	Apr. 01, 2018
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On March 27, 2018, our Board of Directors authorized the redemption of all outstanding preferred share purchase rights issued pursuant to the then existing Rights Agreement (commonly known as a “poison pill”). Under the former Rights Agreement, one right was attached to each outstanding share of common stock. The rights were redeemed at a redemption price of $0.01 per right, payable in cash. The redemption payment was made on April 6, 2018 to the holders of the rights as of the close of business on March 27, 2018. We accrued approximately $0.4 million for the redemption of the Rights Agreement as of April 1, 2018. On April 5, 2018, we repurchased the remaining €56.9 million of the €200.0 million 2023 Notes outstanding as well as $11.3 million of the $200.0 million 2024 Notes outstanding, and we expect to recognize a loss on debt extinguishment of approximately $3.0 million in the second quarter.